Apollo Hospitals to raise $200 mn by selling 6% stake in online platform
In May, Apollo's fourth-quarter revenue from healthcare services climbed 18.5% and accounted for 51% of its total revenue02-06-2023
02-06-2023
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Meeting Updates
as per annexure enclosed02-06-2023
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Intimation Regarding The Change In Date Of The 42Nd Annual General Meeting (AGM)
as per annexure enclosed02-06-2023
Apollo Hospitals share price rises over 4%; should you buy this stock? Here's what top brokerages say
Apollo's presence in an offline format makes it a formidable player, said Prabhudas Lilladher. Motilal Oswal Financial Services maintained a buy call while Kotak Institutional Equities also kept a buy call.01-06-2023
Q4FY23 Quarterly & FY23 Annual Result Announced for Apollo Hospitals Enterprise Ltd.
Healthcare Facilities company Apollo Hospitals Enterprise announced Q4FY23 & FY23 results: Q4FY23: Revenues grew 21% to Rs 43,022 million vs Rs 35,464 million in Q4FY22 EBITDA excluding 24/7 Operating Cost and ESOP charge stood at Rs 706 million; 29% YoY growth Apollo 24/7 cost of Rs 2,174 million in the quarter (including Rs 281 million non-cash ESOP charge) vs Rs 841 million in Q4FY22 EBITDA post 24/7 Operating Cost and ESOP charge at Rs 4,882 million vs Rs 4,632 million in Q4FY22; 5% YoY growth PAT grew 60% to Rs 1,445 million vs Rs 901 million in Q4FY23 Diluted EPS of Rs 10.05 per share in Q4FY23 (not annualised) FY23: Revenues grew 13% to Rs 166,125 million vs Rs 146,626 million in FY22 EBITDA excluding 24/7 Operating Cost and ESOP charge stood at Rs 27,851 crore ;16% YoY growth Apollo 24/7 cost of Rs 7,355 million for the full year (including Rs 781 million non-cash ESOP charge) vs Rs 2,236 million in FY22 EBITDA post 24/7 Operating Cost and ESOP charge at Rs 20,496 million vs Rs 21,851 million in FY22 PAT stood at Rs 8,191 million vs of Rs 10,556 million in FY22 Diluted EPS of Rs 56.97 per share in FY23 Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “The first full post-pandemic year has seen Apollo make some remarkable strides in its journey of healing. Our unwavering commitment to deliver world-class healthcare has enabled us to scale new heights with our performance - both in terms of financial metrics and in the expansion of our healthcare service offerings. We have seen a substantial increase in patient engagement both in our hospitals and clinics, as well as on our digital health platform Apollo 24/7. We have continued to broaden our services, ensuring that we focus not just on cure, but on preventive healthcare as well. At a time when the world is realizing the importance of prevention more than ever before, it is a matter of pride that Apollo has been at the forefront of this shift, recognizing that the best way to fight disease is to prevent it in the first place. One of our areas of focus is Artificial Intelligence (Al), which we believe holds the power to revolutionize preventive healthcare, by helping identify patterns, predict health risks, and enable early interventions. This year, we have invested thoughtfully in Al technologies, and the results have been heartening. They have allowed us to provide a personalized healthcare approach for every individual, taking into account their unique genetic disposition, lifestyle, and medical history." Result PDF01-06-2023
Apollo Hospitals Enterprise Results Earnings Call for Q4FY23
Conference Call with Apollo Hospitals Enterprise Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.31-05-2023
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
as per annexure enclosed31-05-2023
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations, 2015 (Regulations) regarding loss of share certificate. This is to inform you that the Company has received intimation from shareholders on May 30, 2023 regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos. 4453 Malini Shunmugam C R Shunmugam 100 354454 5707641 to 5707740 8706 C R Shunmugam C T Radhakrishnan 20 358709 7547195 to 7547214 This is for your information.31-05-2023
Apollo Hospitals targeting improved occupancy to drive earnings growth
There will be a higher focus on insurance penetration and engaging more with retail and corporates, Apollo said31-05-2023
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
as per annexure enclosed30-05-2023